Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT04853212

The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-03-19

100

Participants Needed

1

Research Sites

254 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective of this case-control study aims to explore the role of bacterium Ruminococcus gnavus (R. gnavus) with intestinal biopsy and faecal sampling in the initiation and the development of spondyloarthritis (SPA) in comparison with health control subjets (patients without chronic disease but have indication to digestive endoscopy).

CONDITIONS

Official Title

The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients 18 years or older diagnosed with spondyloarthritis (SpA) according to ASAS classification
  • Affiliated with a social security scheme
  • Have signed the written informed consent form
  • Control subjects 18 years or older without SpA but planned for digestive endoscopy for other reasons
  • Control subjects affiliated with a social security scheme
  • Control subjects have signed the written informed consent form
Not Eligible

You will not qualify if you...

  • Unable to understand the study or sign informed consent
  • Pregnant or breastfeeding women
  • Under guardianship or curatorship
  • Taken antibiotics within 1 month prior to inclusion
  • Have acute or chronic severe conditions interfering with study outcomes
  • Refuse to participate in the study
  • Foreign patients under French AME scheme

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Service de Rhumatologie, Hôpital Ambroise Paré, APHP

Boulogne-Billancourt, France, 92100

Actively Recruiting

Loading map...

Research Team

M

Maxime BREBAN, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here